CSSI - Costas, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
+0.0198 (+31.83%)
At close: 12:18PM EDT
Stock chart is not supported by your current browser
Previous Close0.0622
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0820 - 0.0820
52 Week Range0.0130 - 0.2200
Avg. Volume39,756
Market Cap1.171M
Beta (3Y Monthly)-0.73
PE Ratio (TTM)N/A
EPS (TTM)-0.0780
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire26 days ago

    Atlas Nanotech of Guadalajara to begin alliance with European Nano Medical S.R.O.

    GUADALAJARA, Mexico, June 27, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – CSSI (Costas Inc.) DBA Atlas Nanotech has entered an accord with Nano Medical S.R.O. of the Czech Republic. Atlas has successfully completed the submission of documentation and payment for two unique nanotechnology products through the Mexican regulator COFEPRIS. Initially, Atlas plans to distribute Nano Medical S.R.O.’s products in Mexico and, eventually, throughout Latin America, while Nano Medical S.R.O will distribute Atlas Nanotech’s products in Europe.

  • GlobeNewswire2 months ago

    COSTAS Inc. (CSSI) Acquires Medical Nanotechnology Company, Appoints New Management and Board Members

    LAS VEGAS, June 06, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – COSTAS,Inc.  (CSSI), announces its acquisition of Atlas Nanotech (formerly known as Nano Creaciones SAPI de CV) in an all-stock transaction that marks the Company’s entrance into the multi-billion-dollar global nanomedicine marketplace. The terms of the share exchange agreement include the appointment of new managing officers and a new board of directors, the resignation of COSTA’s current officers and board of directors and the retirement of 12,660,000 shares. The principles of Atlas are receiving 25,000,000 shares of CSSI subject to a lock-up agreement with staggered release of shares over a 2-year period.

  • GlobeNewswire7 months ago

    Costas, Inc. Anticipates Recently Signed Farm Bill to Have Significant Impact on CSSI Initiatives in Hemp, Cannabis Industry

    NEW YORK, Dec. 31, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Costas Inc. (OTC MARKETS:CSSI) (CSSI or “the Company) is pleased to announce that, in the wake of the $867 billion 2018 Farm Bill having been signed into Law, the Company is entering the Cannabis industry which will include multiple acquisitions and operations in the sector to include extraction, processing, marketing and distribution.  The Company Board has approved purchasing of extraction equipment and partnerships with select cultivators in processing multiple product lines. “The 2018 Farm Bill includes an amendment that removes hemp from the list of controlled substances under federal law. This legalizes, federally, hemp cultivation which could lead to a potential of additional 1 million jobs in the United States for 2019.  Our team agrees that the industry is poised for seismic growth and Costas will position itself strategically for meaningful participation in the market.

  • GlobeNewswire8 months ago

    Costas Inc. Announces Appointment of J.D. Brammer as New Chief Executive Officer and Director; Share Retirement

    NEW YORK, Nov. 29, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Costas Inc. (OTC MARKETS:CSSI) Costas Inc. (CSSI or “the Company”) is proud to announce the appointment of J.D. Brammer as the new Chief Executive Officer and Director of the Company. Mr. Brammer’s appointment was made as a strategic step by the Company to pursue pending opportunities in the on-line gaming business. It will be abandoning its efforts to pursue its cryptocurrency initiatives because it has been offered a more immediately profitable venture in the online gaming market place.  As part of this change, the major stockholders have agreed to relinquish over 14,000,000 shares of their existing CSSI common stock in order to support this new initiative.